Evidence map›Paper›PMID 30580383›Full record

ArticleActa neuropathologica2019

Microglial cell loss after ischemic stroke favors brain neutrophil accumulation.

Amaia Otxoa-de-Amezaga, Francesc Miró-Mur, Jordi Pedragosa, Mattia Gallizioli, Carles Justicia, Núria Gaja-Capdevila, Francisca Ruíz-Jaen, Angélica Salas-Perdomo, Anna Bosch, Maria Calvo and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 176 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 1 synthesis or guideline pooled it, 260 citations in OpenAlex.

  1. Pooled it
  2. An integrated investigation of systemic and localized pathophysiological mechanisms of stroke and multimodal therapeutic strategies.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  3. Article
  4. Lipid metabolism, microglia, and stroke.Neural regeneration research · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. The Role of TNF-α in Ischemic Stroke.International journal of molecular sciences · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Bradykinin Type 2 Receptor Deficiency Reshapes Acute Neuroinflammation and Improves Cell Survival after Ischemic Stroke in Diabetic Mice.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  19. Review
  20. Article

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Amaia Otxoa-de-AmezagaDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Francesc Miró-MurArea of Neuroscience, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Jordi PedragosaDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Mattia GallizioliDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Carles JusticiaDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Núria Gaja-CapdevilaDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Francisca Ruíz-JaenDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Angélica Salas-PerdomoDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Anna BoschScientific and Technological Centers, Universitat de Barcelona (CCiTUB) Campus Medicina Clínic, Barcelona, Spain.
Maria CalvoScientific and Technological Centers, Universitat de Barcelona (CCiTUB) Campus Medicina Clínic, Barcelona, Spain.
Leonardo Márquez-KisinouskyDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España.
Adam DenesLaboratory of Neuroimmunology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Matthias GunzerInstitute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen, Germany.
Anna M PlanasDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Rossello 161 planta 6, Barcelona, 08036, España. anna.planas@iibb.csic.es.
Institut d'Investigacions Biomèdiques de Barcelona · ESConsejo Superior de Investigaciones Científicas · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversitat de Barcelona · ESHUN-REN Institute of Experimental Medicine · HUUniversity of Duisburg-Essen · DE

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2014-56279-RMinisterio de Economía, Industria y Competitividad, Gobierno de España SAF2017-87459-R
6 · The paper itself

Abstract

Stroke attracts neutrophils to the injured brain tissue where they can damage the integrity of the blood-brain barrier and exacerbate the lesion. However, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated. Neutrophils can reach the perivascular spaces of brain vessels after crossing the endothelial cell layer and endothelial basal lamina of post-capillary venules, or migrating from the leptomeninges following pial vessel extravasation and/or a suggested translocation from the skull bone marrow. Based on previous observations of microglia phagocytosing neutrophils recruited to the ischemic brain lesion, we hypothesized that microglial cells might control neutrophil accumulation in the injured brain. We studied a model of permanent occlusion of the middle cerebral artery in mice, including microglia- and neutrophil-reporter mice. Using various in vitro and in vivo strategies to impair microglial function or to eliminate microglia by targeting colony stimulating factor 1 receptor (CSF1R), this study demonstrates that microglial phagocytosis of neutrophils has fundamental consequences for the ischemic tissue. We found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils first in perivascular spaces and later in the parenchyma. Accordingly, microglia depletion by long-term treatment with a CSF1R inhibitor increased the numbers of neutrophils and enlarged the ischemic lesion. Hence, microglial phagocytic function sets a critical line of defense against the vascular and tissue damaging capacity of neutrophils in brain ischemia.

Indexed as

AnimalsBlood-Brain BarrierBrainBrain InjuriesBrain IschemiaDisease Models, AnimalHumansMaleMice, Inbred C57BLMicrogliaNeutrophilsPhagocytosisStrokeBrain ischemiaColony stimulating factor 1 receptorHumanMicrogliaMouseNeutrophilsPhagocytosis

Identifiers

PMID30580383
PMCPMC6513908
OpenAlexW2906438829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.